Table 2.
Comparison of patients regarding gender with (Intervention I) and without cross-linking (Control C) in all tests: long-term visual functioning scale (LFVFS), long-term socioemotional scale (LFSES), EQ-5D-5L (European Quality of Life 5 Dimensions 5 Level Version), and EQ-VAS (European Quality of Life Visual Analog Scale) at different visits (V).
| LFVFS | LFSES | EQ-VAS | EQ 5D 5L | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | p | All | Male | Female | p | All | Male | Female | p | All | Male | Female | p | All | |
| C n = | 31 | 6 | 37 | 31 | 6 | 37 | 31 | 6 | 37 | 31 | 6 | 37 | ||||
| C V1 | 75.1 | 76.1 | 0.9 | 75.2 | 89.8 | 100.0 | 0.00004 * | 91.1 | 81.8 | 80.8 | 0.9 | 81.7 | 0.94 | 0.966 | 0.4 | 0.95 |
| C V6 | 77.9 | 72.4 | 0.5 | 76.8 | 88.0 | 94.3 | 0.2 | 89.1 | 81.1 | 73.8 | 0.3 | 79.7 | 0.931 | 0.922 | 0.6 | 0.93 |
| I n = | 24 | 7 | 31 | 24 | 7 | 31 | 24 | 7 | 31 | 24 | 7 | 31 | ||||
| I V1 | 68.7 | 64.3 | 0.6 | 67.7 | 86.0 | 96.2 | 0.05 * | 87.6 | 78.2 | 79.3 | 0.9 | 78.5 | 0.92 | 0.87 | 0.6 | 0.90 |
| I V2 | 58.5 | 54.3 | 57.4 | 83.7 | 100.0 | 85.4 | 56.6 | 55.8 | 56.4 | 0.61 | 0.516 | 0.59 | ||||
| I V3 | 68.3 | 72.3 | 69.3 | 81.7 | 99.0 | 84.3 | 80.9 | 79.3 | 80.5 | 0.91 | 0.929 | 0.92 | ||||
| I V4 | 70.3 | 75.5 | 71.6 | 90.2 | 89.3 | 90.0 | 82.6 | 85.3 | 83.2 | 0.94 | 0.96 | 0.94 | ||||
| I V5 | 71.6 | 79.2 | 73.5 | 85.5 | 82.3 | 84.9 | 84.6 | 78.0 | 83.0 | 0.94 | 0.956 | 0.94 | ||||
| I V6 | 78.7 | 75.9 | 0.6 | 77.9 | 92.0 | 98.5 | 0.03 * | 93.5 | 86.2 | 80.7 | 0.1 | 84.6 | 0.96 | 0.884 | 0.3 | 0.94 |
V1: baseline, V2: +1 d, V3 +1 Week, V4: +4 Weeks, V5: +3 months, V6: +6 months. * Differences between subgroups are significant (p < 0.05).